Providing affordable access to new treatment for leukaemia and lymphoma
Federal Member for Page Kevin Hogan said leukaemia and lymphoma patients in our community will benefit from affordable access to a new medicine, with the Federal Government subsidising the drug Ibrutinib. “This new treatment will provide much needed support to patients who don’t respond to other initial treatments,” he said. Ibrutinib (sold as Imbruvica®) would…
